Drug Profile
Zika virus vaccine - Najit Technologies
Latest Information Update: 28 Apr 2022
Price :
$50
*
At a glance
- Originator Najit Technologies
- Class Synthetic vaccines; Zika virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Zika virus infection